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Figure 1. Normally, increased dietary salt does not increase blood pressure, in part due to the protective
effects of prostacyclin (PGI2) and IP receptor activation
In mice lacking the IP receptor, increased BP and cardiac fibrosis ensue. The fibrosis depends on thrombox-
ane-receptor activation since it does not occur in mice lacking the TP receptor. This pathway might contribute
to the cardio-protective effects of low-dose aspirin, which inhibits thromboxane synthesis and injurious effects
of COX-2 inhibitors, which in turn inhibits prostacyclin production.
mouse. Conversely, if other cells synthe-
size the prostanoids activating the TP
receptor, thromboxane synthesis inhibi-
tors or receptor antagonists might pro-
vide an effective therapeutic approach
to heart disease in patients taking
NSAIDs. Ultimately, through the dissec-
tion of these intricate pathways, it may
be possible to identify drugs that pro-
vide all the therapeutic effects of NSAIDs
and COXIBS but lack their adverse side
effects. Until that time, one can only
marvel at the combination of therapeutic
and cardioprotective effects of nature’s
own compound, salicylate, and its chem-
ically modified derivative, aspirin (Figure 1).
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Insulin regulates glucose transport in muscle and fat cells by stimulating the translocation of GLUT4 from intracellular
vesicles to the plasma membrane. In this issue of Cell Metabolism, Holman and colleagues (Koumanov et al., 2005) recon-
stitute this process in vitro, providing a system that promises new breakthroughs in our understanding of this important
metabolic process.Regulation of glucose homeostasis by
insulin comprises a number of steps. One
is the transport of glucose into muscle
and fat cells, which is mediated by the
glucose transporter GLUT4 (Bryant et
a
i
t
t
c150l., 2002). The shuttling of GLUT4 from
ntracellular storage vesicles (GSVs) to
he plasma membrane (PM) in response
o insulin lies at the intersection of vesi-
le transport and signal transduction re-
s
t
w
w
aearch. GSVs, containing GLUT4 and
he v-SNARE VAMP2, fuse infrequently
ith the PM in the absence of insulin,
hereas in its presence, exocytosis is
ugmented. PI 3# kinase and Akt play aCELL METABOLISM : SEPTEMBER 2005
P R E V I E Wkey role in GSV exocytosis, but the
downstream targets of Akt that intersect
with GLUT4 trafficking remain out of
reach. One limitation is that it is not
known which step(s) in the GLUT4 traf-
ficking pathway is regulated by insulin.
Candidates include GSV formation, traf-
ficking along cytoskeletal tracks, and a
variety of steps at the target membrane
including tethering, docking, or fusion.
Some mechanistic details of these steps
are known; for example, the encounter
of GSVs with the PM involves the SNARE
proteins VAMP2, Syntaxin4, and SNAP23,
and SNARE-associated proteins such
as the Sec1p-like protein Munc18c.
However, several difficulties have hin-
dered identification of the signal that is
transmitted from insulin via Akt to regu-
late GLUT4 translocation. First, separat-
ing GLUT4 translocation to the PM into
discrete experimentally tractable steps
has not been possible. Second, GLUT4
is localized to multiple intracellular com-
partments including the TGN and endo-
somes, and the relationship between
these compartments and GSVs is not
known. Further complicating matters, in-
sulin also increases endosomal recycling,
possibly via a different mechanism to GSV
exocytosis. Finally, Akt is a rather promis-
cuous signaling intermediate with a po-
tential role in almost all the metabolic ac-
tions of insulin signaling. Does insulin
increase GLUT4 translocation by manipu-
lating just one rate-controlling step, or
does it involve manipulation of a series of
overlapping steps? The limitations in an-
swering this most significant question
may be overcome by the development of
new assays to study GLUT4 transloca-
tion, and the work of Holman et al. (Kou-
manov et al., 2005) constitutes an impor-
tant step in this direction.
A major breakthrough in vesicle trans-
port research was the in vitro reconstitu-
tion of intra Golgi vesicle transport by
James Rothman and colleagues (Balch
et al., 1984). This landmark achieve-
ment, combined with genetic studies in
yeast, produced a blueprint for the mo-
lecular regulation of all vesicle transport
steps in eukaryotic cells. While this ap-
proach was successfully applied to a
number of constitutive transport pro-
cesses, regulated transport events, partic-
ularly those involving the PM, have been
less compliant. A major disadvantage of
many of the described PM-fusion assays
is that they have not been able to distin-
guish between attachment of transport
vesicles to the PM and fusion of the two
bilayers. Despite several attempts (Inoue
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wCELL METABOLISM : SEPTEMBER 2005t al., 1999; Murata et al., 2003), there has
een little progress in reconstituting the
nsulin-regulated trafficking of GLUT4
rom GSVs to the PM in vitro.
Holman and colleagues (Koumanov et
l., 2005) have overcome this barrier and
escribe an elegant system that reconsti-
utes regulated fusion of GSVs with the
M in vitro. This achievement relies on
everal unique adaptations: the use of a
luorescently tagged glucose analog to la-
el intracellular GSVs; a novel method for
urifying native GSVs for use in the assay;
nd reconstitution of the PM into artificial
iposomes that will allow fusion to be de-
ected. After incubating GSVs with artifi-
ial PMs, each labeled with distinct lume-
al fluorophores, fluorescence resonance
nergy transfer (FRET) was used to detect
ontent mixing and thus fusion of these
wo organelles. Fusion was energy, cyto-
ol, SNARE, and Akt dependent. In per-
aps the most striking finding, PMs from
nsulin-treated adipocytes yielded an 8-fold
igher rate of fusion compared to those
rom noninsulin-treated cells, even when
ixed with cytosol and GSVs obtained
rom basal cells.
This assay eliminates a number of
ariables, including long-range move-
ent of GSVs along microtubules, and
he participation of endosomes and TGN
n the translocation process. Hence, ma-
or conclusions from this study are that
usion of GSVs with the PM is a rate-
imiting step in the insulin regulation of
lucose transport and that most of the
egulation occurs at the PM. A number
f other recent studies have hinted at a
imilar mechanism (Bose et al., 2004;
anda et al., 2005; van Dam et al.,
005). But what is this insulin-regulated
tep, and will this assay speed its dis-
overy? The assay depends on the iso-
ation of PM from an insulin-stimulated
ell that is able to recruit and activate
ytosolic Akt. Hence, one possibility is
hat the major insulin-regulated step in
his assay is Akt recruitment to the PM.
his raises two questions. First, what in-
ulin responsive factor(s) in the PM cata-
yze Akt recruitment? Koumanov et al.,
2005) attribute this to PIP3 that is car-
ied through during PM isolation from
he insulin-treated cell. However, PIP3 is
ighly labile, and so until PM PIP3 levels
re measured, this key point remains un-
nswered. Second, where are the key
ubstrates of Akt that trigger GSV fu-
ion? While it seems likely from this
ork that there is a requirement for Akt
a
p
i
c
s
o
v
P
f
t
o
s
f
f
v
t
d
c
c
t
n
m
t
l
n
o
p
m
r
l
f
t
t
a
f
r
k
c
(
c
a
w
t
s
d
i
m
i
t
i
2
P
t
w
A
m
v
i
at the PM this still does not eliminate the
ossibility that the substrates are either
n the GSVs themselves or even re-
ruited to the fusion site from the cyto-
ol. Furthermore, the study does not rule
ut a requirement for other insulin-acti-
ated components in the reconstituted
M. Therefore, it will be important in the
uture to investigate the role of lipids in
his assay and to better define the role
f PM versus cytosolic Akt in GLUT4 fu-
ion, both of which should be feasible.
How can this assay be used most ef-
ectively and what advantages does it of-
er? With rare exceptions, the utility of in
itro vesicle fusion assays as discovery
ools has been limited by the immense
ifficulty in using such experimentally
omplex assays to purify homogeneous
omponents. In all likelihood, therefore,
his system will be most useful as a diag-
ostic assay to test the role of individual
olecules already implicated in GLUT4
rafficking. As indicated in Figure 1, this
ist is quite vast, and so the addition of
eutralizing antibodies or fusion proteins
r the immunodepletion of specific targets
rior to the assay, as exemplified by re-
oval of Akt from the cytosol in the cur-
ent study (Koumanov et al., 2005), will
ikely provide novel and perhaps more de-
initive insights. Moreover, this assay sys-
em may lend itself to minor adaptations
o further extend its capabilities. For ex-
mple, the use of components isolated
rom cell systems expressing either
ecombinant molecules or siRNAs to
nock down the expression of key mole-
ules would offer a major advance.
Assuming that Holman and colleagues
Koumanov et al., 2005) are correct in
oncluding that this assay demonstrates
major effect of insulin on GSV fusion
ith the PM, then the next challenge is
o break this reaction down into its con-
tituent parts, namely vesicle tethering,
ocking, priming, and fusion. The exist-
ng literature already implicates many
olecules acting at each of these steps
n GLUT4 trafficking. Among these are
he exocyst complex, whose localization
s regulated by insulin (Inoue et al.,
003); Munc18c, which is required for
I-3#-kinase regulated GSV transloca-
ion (Kanda et al., 2005); and AS160
hich is a RabGAP phosphorylated by
kt (Sano et al., 2003). Does insulin
odify each of these molecules in the in
itro assay in a predictable way, or does
nsulin regulation in this system involve
novel target? Now, after waiting 15151
P R E V I E WFigure 1. Overview of molecules involved in insulin-stimulated GLUT4 translocation
Two major signal transduction pathways have been implicated: the IRS1/PI3Kinase/Akt pathway leading to phosphorylation of the RabGAP AS160 and the Cbl/TC10
pathway, which has been linked to the exocyst complex and to actin reorganization. GLUT4 translocation involves several steps including reorganization of actin,
transport of GSVs to the cell surface, and tethering, docking, and fusion of GSVs at the PM. Additionally, a number of molecules have been associated with the
formation of GSVs. Studying GLUT4 trafficking in molecular detail has been complicated by the number of steps involved (also including trafficking between the trans-
Golgi network, endosomes, and GSVs). A new in vitro fusion assay between PM liposomes and GSVs (Koumanov et al., 2005) will allow investigators to dissect GLUT4
translocation to the PM and to test the insulin regulation of molecules involved in the tethering, docking, and fusion step.years for the assay to become available,
we may be able to find out. In view of
the vast array of molecules potentially
implicated in GLUT4 trafficking, it is
likely investigators in this field will now
be able to work through this list to sim-
plify what has hitherto been an experi-
mentally intractable problem.
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